Additional Information
Book Details
Abstract
This issue, edited by Dr. Rakesh Kumar, reviews current clinical information in "PET Based Interventions." Articles will include: PET/CT in Radiofrequency Ablation; PET/CT Guided FNAC/Biopsy; PET/CT in Radiotherapy Planning; Dual Time Point Imaging; The Role of PET in Radiation Oncology; PET/CT in Individualization of Treatment (Personalized medicine); Ga68-DOTA-TOC PET/CT in targeted radionuclide therapy (Lu188 therapy for NET); Role of FDG PET/CT in Targeted Radionuclide Therapy of Endocrine Malignancies; Overview of Conventional Imaging Based Intervention in Clinical Practice; Special Techniques in PET/CT in Evaluating Genito-urinary Malignancies; and more!
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Contributors | iii | ||
| CONSULTING EDITOR | iii | ||
| EDITOR | iii | ||
| AUTHORS | iii | ||
| Contents | v | ||
| Preface: PET/Computed Tomography-based Interventionxi | v | ||
| Role of Fluorodeoxyglucose PET/Computed Tomography in Targeted Radionuclide Therapy for Endocrine Malignancies461 | v | ||
| Application and Dosimetric Requirements for Gallium-68–labeled Somatostatin Analogues in Targeted Radionuclide Therapy for ... | v | ||
| PET/Computed Tomography in the Individualization of Treatment of Prostate Cancer487 | v | ||
| PET/Computed Tomography Using New Radiopharmaceuticals in Targeted Therapy495 | vi | ||
| PET/Computed Tomography in Evaluation of Transarterial Chemoembolization507 | vi | ||
| PET/Computed Tomography and Thermoablation (Radiofrequency, Microwave, Cryotherapy, Laser Interstitial Thermal Therapy)519 | vi | ||
| Utility of PET for Radiotherapy Treatment Planning541 | vi | ||
| Applications of Fluorodeoxyglucose PET/Computed Tomography in the Assessment and Prediction of Radiation Therapy–related Co ... | vi | ||
| PET/Computed Tomography-based Intervention | xi | ||
| Role of Fluorodeoxyglucose PET/Computed Tomography in Targeted Radionuclide Therapy for Endocrine Malignancies | 461 | ||
| Key points | 461 | ||
| INTRODUCTION | 461 | ||
| MECHANISM OF FLUORODEOXYGLUCOSE UPTAKE IN ENDOCRINE MALIGNANCY | 462 | ||
| ROLE OF FLUORODEOXYGLUCOSE PET/COMPUTED TOMOGRAPHY IN THE MANAGEMENT OF GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS | 463 | ||
| FLUORODEOXYGLUCOSE VERSUS SOMATOSTATIN RECEPTOR PET/CT | 464 | ||
| ROLE OF FLUORODEOXYGLUCOSE PET/COMPUTED TOMOGRAPHY IN THE MANAGEMENT OF DIFFERENTIATED THYROID CANCER | 468 | ||
| ROLE OF FLUORODEOXYGLUCOSE PET/CT IN THE MANAGEMENT OF MEDULLARY THYROID CANCER | 470 | ||
| ROLE OF FLUORODEOXYGLUCOSE PET/COMPUTED TOMOGRAPHY IN THE MANAGEMENT OF PHEOCHROMOCYTOMA AND PARAGANGLIOMA | 471 | ||
| ROLE OF FLUORODEOXYGLUCOSE PET/COMPUTED TOMOGRAPHY IN THE MANAGEMENT OF ADRENOCORTICAL CARCINOMA | 474 | ||
| SUMMARY | 474 | ||
| REFERENCES | 474 | ||
| Application and Dosimetric Requirements for Gallium-68–labeled Somatostatin Analogues in Targeted Radionuclide Therapy for ... | 477 | ||
| Key points | 477 | ||
| CURRENT VIEWS ON THE MOLECULAR ORIGINS OF GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS | 477 | ||
| CURRENT MANAGEMENT OF METASTATIC GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS | 478 | ||
| SOMATOSTATIN PET/COMPUTED TOMOGRAPHY USING GALLIUM-68–LABELED SOMATOSTATIN ANALOGUES | 478 | ||
| GALLIUM-68–LABELED SOMATOSTATIN ANALOGUES AS THERANOSTICS FOR GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS | 479 | ||
| PROGNOSTIC VALUE AND TUMOR RESPONSE ASSESSMENT TO PEPTIDE RECEPTOR RADIONUCLIDE THERAPY | 482 | ||
| INTERNAL DOSIMETRY | 483 | ||
| SUMMARY | 484 | ||
| REFERENCES | 485 | ||
| PET/Computed Tomography in the Individualization of Treatment of Prostate Cancer | 487 | ||
| Key points | 487 | ||
| INTRODUCTION | 487 | ||
| CHOLINE PET/COMPUTED TOMOGRAPHY TO GUIDE SALVAGE RADIOTHERAPY | 488 | ||
| CHOLINE PET/COMPUTED TOMOGRAPHY TO GUIDE SALVAGE LYMPH NODE DISSECTION | 491 | ||
| IMPACT OF PET-GUIDED THERAPIES ON TREATMENT STRATEGY | 491 | ||
| SUMMARY | 492 | ||
| REFERENCES | 492 | ||
| PET/Computed Tomography Using New Radiopharmaceuticals in Targeted Therapy | 495 | ||
| Key points | 495 | ||
| TARGETED THERAPY AND PET/COMPUTED TOMOGRAPHY IMAGING | 495 | ||
| PET/COMPUTED TOMOGRAPHY IMAGING OF CELL SURFACE RECEPTORS | 496 | ||
| PET/COMPUTED TOMOGRAPHY IMAGING OF HORMONAL RECEPTOR | 500 | ||
| PET/COMPUTED TOMOGRAPHY IMAGING OF RECEPTOR TYROSINE KINASE | 500 | ||
| PET/COMPUTED TOMOGRAPHY IMAGING OF ANGIOGENESIS | 501 | ||
| REFERENCES | 501 | ||
| PET/Computed Tomography in Evaluation of Transarterial Chemoembolization | 507 | ||
| Key points | 507 | ||
| INTRODUCTION | 507 | ||
| TRANSARTERIAL CHEMOEMBOLIZATION DEFINITION AND TYPES | 508 | ||
| RADIOEMBOLIZATION | 510 | ||
| PRETREATMENT IMAGING | 510 | ||
| ASSESSMENT OF TREATMENT RESPONSE | 510 | ||
| REFERENCES | 515 | ||
| PET/Computed Tomography and Thermoablation (Radiofrequency, Microwave, Cryotherapy, Laser Interstitial Thermal Therapy) | 519 | ||
| Key points | 519 | ||
| INTRODUCTION | 519 | ||
| DIFFERENT THERMOABLATION TECHNIQUES | 520 | ||
| GOALS OF THE PET/COMPUTED TOMOGRAPHY | 520 | ||
| INTERPRETATION AND IMAGE PATTERNS | 521 | ||
| RESULTS IN DIFFERENT SITUATIONS | 521 | ||
| REAL-TIME GUIDING THERMAL ABLATION | 531 | ||
| LIMITS OF 18F-FLUORODEOXYGLUCOSE PET/COMPUTED TOMOGRAPHY | 532 | ||
| SUMMARY | 533 | ||
| REFERENCES | 535 | ||
| Utility of PET for Radiotherapy Treatment Planning | 541 | ||
| Key points | 541 | ||
| OVERVIEW OF 18F-2-FLUORO-2-DEOXY-D-GLUCOSE PET | 541 | ||
| PET/COMPUTED TOMOGRAPHY SIMULATION TECHNIQUE | 542 | ||
| TREATMENT PLANNING AND CLINICAL IMPLICATIONS | 542 | ||
| SUMMARY | 549 | ||
| REFERENCES | 549 | ||
| Applications of Fluorodeoxyglucose PET/Computed Tomography in the Assessment and Prediction of Radiation Therapy–related Co ... | 555 | ||
| Key points | 555 | ||
| INTRODUCTION | 555 | ||
| RADIATION-INDUCED LUNG INFLAMMATION | 556 | ||
| CARDIAC COMPLICATIONS | 562 | ||
| EFFECT OF RADIATION ON THE CENTRAL NERVOUS SYSTEM | 564 | ||
| RADIATION-INDUCED ESOPHAGITIS | 565 | ||
| PET/COMPUTED TOMOGRAPHY FOR EVALUATION OF INSUFFICIENCY FRACTURES | 565 | ||
| SALIVARY GLAND INJURY AFTER RADIATION THERAPY | 566 | ||
| PET/COMPUTED TOMOGRAPHY AS A PREDICTOR OF HEMATOLOGICAL TOXICITY AFTER RADIATION THERAPY | 566 | ||
| SUMMARY | 566 | ||
| REFERENCES | 567 |